Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/Naloxone vs Oxycodone for Cancer Pain (TOP)
NCT01313780Phase 4Completed
- Sponsor
- Mundipharma
- Start
- May 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxycodone + naloxone in cancer pain, sponsored by Mundipharma. Started May 2011; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01313780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313780.